carbamates has been researched along with Carcinoma, Epidermoid in 11 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "ERBB2 status in head and neck squamous cell carcinoma (HNSCC) has not been well studied." | 1.43 | Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma. ( Birkeland, AC; Bradford, CR; Brenner, JC; Carey, TE; Foltin, SK; Komarck, CM; Ludwig, ML; Mann, JE; McHugh, JB; Michmerhuizen, NL; Prince, ME; Sandelski, MM; Scott, MV; Spector, ME; Tillman, BN; Yanik, M, 2016) |
| "In head and neck squamous cell carcinoma (HNSCC), resistance to single-agent targeted therapy may be overcome by co-targeting of compensatory signaling pathways." | 1.42 | Synergistic apoptosis in head and neck squamous cell carcinoma cells by co-inhibition of insulin-like growth factor-1 receptor signaling and compensatory signaling pathways. ( Axelrod, MJ; Capaldo, B; Conaway, M; Gioeli, DG; Jameson, MJ; Khalil, A; Leimgruber, SS; Mendez, RE; Sharlow, ER; Weber, MJ, 2015) |
| "Rat nasal squamous cell carcinomas induced by inhalation of three direct-acting alkylating agents yielded DNA containing activated oncogenes with no homology to any member of the ras family." | 1.27 | Detection of novel non-ras oncogenes in rat nasal squamous cell carcinomas. ( Currie, DD; Felber, M; Garte, SJ; Hochwalt, AE; Wirgin, I, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (54.55) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robert, C | 1 |
| Axelrod, MJ | 1 |
| Mendez, RE | 1 |
| Khalil, A | 1 |
| Leimgruber, SS | 1 |
| Sharlow, ER | 1 |
| Capaldo, B | 1 |
| Conaway, M | 1 |
| Gioeli, DG | 1 |
| Weber, MJ | 1 |
| Jameson, MJ | 1 |
| Adelmann, CH | 1 |
| Ching, G | 1 |
| Du, L | 1 |
| Saporito, RC | 1 |
| Bansal, V | 1 |
| Pence, LJ | 1 |
| Liang, R | 1 |
| Lee, W | 1 |
| Tsai, KY | 1 |
| Birkeland, AC | 1 |
| Yanik, M | 1 |
| Tillman, BN | 1 |
| Scott, MV | 1 |
| Foltin, SK | 1 |
| Mann, JE | 1 |
| Michmerhuizen, NL | 1 |
| Ludwig, ML | 1 |
| Sandelski, MM | 1 |
| Komarck, CM | 1 |
| Carey, TE | 1 |
| Prince, ME | 1 |
| Bradford, CR | 1 |
| McHugh, JB | 1 |
| Spector, ME | 1 |
| Brenner, JC | 1 |
| Torres, MA | 1 |
| Raju, U | 1 |
| Molkentine, D | 1 |
| Riesterer, O | 1 |
| Milas, L | 1 |
| Ang, KK | 1 |
| MECHL, Z | 1 |
| KOLAR, V | 1 |
| KONECNY, M | 1 |
| Hochwalt, AE | 1 |
| Wirgin, I | 1 |
| Felber, M | 1 |
| Currie, DD | 1 |
| Garte, SJ | 1 |
| Van Duuren, BL | 1 |
| Goldschmidt, BM | 1 |
| Katz, C | 1 |
| Seidman, I | 1 |
| Pound, AW | 1 |
| Bardos, TJ | 1 |
| Ambrus, JL | 1 |
| Ambrus, CM | 1 |
| Boronow, RC | 1 |
| Borromeo, RG | 1 |
1 review available for carbamates and Carcinoma, Epidermoid
| Article | Year |
|---|---|
[What's new in oncodermatology?]
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Ben | 2018 |
10 other studies available for carbamates and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Synergistic apoptosis in head and neck squamous cell carcinoma cells by co-inhibition of insulin-like growth factor-1 receptor signaling and compensatory signaling pathways.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carbamates; Carcinoma, Squamous Cell; Cel | 2015 |
Comparative profiles of BRAF inhibitors: the paradox index as a predictor of clinical toxicity.
Topics: Apoptosis; Carbamates; Carcinoma, Squamous Cell; Cell Line; Cell Line, Tumor; Enzyme Activation; Het | 2016 |
Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.
Topics: Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Carbamates; Carcinoma, Squamous Cell; Ce | 2016 |
AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo.
Topics: Animals; Apoptosis; Blotting, Western; Carbamates; Carcinoma, Squamous Cell; Cell Count; Cell Cycle; | 2011 |
THE USE OF THE DRUGS AB 103 AND AB 132 IN THE COMBINED TREATMENT OF TUMOURS OF THE CERVICAL AND PULMONARY REGIONS.
Topics: Alkylating Agents; Antineoplastic Agents; Aziridines; Carbamates; Carcinoma, Bronchogenic; Carcinoma | 1964 |
Detection of novel non-ras oncogenes in rat nasal squamous cell carcinomas.
Topics: Animals; Blotting, Southern; Carbamates; Carcinoma, Squamous Cell; Disease Models, Animal; DNA Restr | 1988 |
Dimethylcarbamyl chloride, a multipotential carcinogen.
Topics: Acylation; Animals; Carbamates; Carcinogens; Carcinoma, Squamous Cell; Chemical Industry; Chlorine; | 1972 |
Tumour formation in mice by urethane administered with related carbamates.
Topics: Animals; Carbamates; Carcinoma; Carcinoma, Squamous Cell; Croton Oil; Drug Interactions; Esters; Inj | 1972 |
Combination of chemotherapy with dual antagonists and radiotherapy in the treatment of neoplastic disease.
Topics: Alkylating Agents; Antimetabolites; Antineoplastic Agents; Azirines; Carbamates; Carcinoma, Bronchog | 1971 |
Porfiromycin (NSC-56410) for disseminated squamous cancer of the cervix.
Topics: Anti-Bacterial Agents; Carbamates; Carcinoma, Squamous Cell; Female; Humans; Uterine Cervical Neopla | 1969 |